Ukwelashwa kwe-CAR - T Cell, I-CAR T Therapy, ISIMOTO SEMOTO, i-agent ye-chimeric
Ukugxumela Okujulile Ku-CAR T Cell Therapy: Isebenza Kanjani?
Zitholele isayensi ngemuva kokwelashwa kwe-CAR T Cell eNdiya! Hlola ukuthi lokhu kwelashwa okuguquguqukayo kuwaguqula kanjani amaseli akho omzimba abe yizilwi zomdlavuza. Funda ibhulogi yethu manje ukuze ufunde kabanzi mayelana nalokhu kwelashwa okuyisimangaliso nokuthi kanjani ..
ISIMOTO SEMOTO, Ukwelashwa kweCAR, immunotherapy, Ukwelashwa kwe-T cell
Ingabe I-CAR T-Cell Therapy Iyatholakala E-India?
Wake wazibuza ukuthi ikhona yini indlela enamandla yokulwa nomdlavuza? Manje ake ucabange nje uma ngolunye usuku uthole umsebe wethemba ekulweni kwakho nomdlavuza, ukwelashwa okusebenzisa amandla amasosha omzimba wakho ukukhomba isifo somdlavuza.
Ukushintsha kwe-IDH1, olutasidenib, i-refractory acute myeloid leukemia, I-Rezlidhia
I-Olutasidenib igunyazwe yi-FDA nge-leukemia e-acute myeloid acute noma e-refractory ene-IDH1 esengozini
Dis 2022: Amaphilisi e-Olutasidenib (Rezlidhia) agunyazwe i-Food and Drug Administration (FDA) ezigulini ezikhulile ezine-acute myeloid leukemia (AML) ehlehla kabusha noma engakwazi ukumelana nokushintshashintsha kwe-IDH1 okungaba sengozini njengoba kuhlonzwa.
I-Asparaginase erwinia chrysanthemi, Imithi yeJazz, I-Rylaze
Uhlobo olusha lokudosa lwe-asparaginase erwinia chrysanthemi (i-recombinant) lugunyazwe yi-FDA
Dec 2022: Uhlelo olusha lokudosa lwangoMsombuluko-ngoLwesithathu-uLwesihlanu lwe-asparaginase erwinia chrysanthemi (i-recombinant)-rywn lugunyazwe i-Food and Drug Administration (Rylaze, Jazz Pharmaceuticals). Iziguli kufanele zithole ama-25 mg/m.
ivosidenib, I-NCT03173248, I-Servier Pharmaceuticals LLC, UTibsovo
I-Ivosidenib ihlanganiswe ne-azacitidine igunyazwe ku-acute myeloid leukemia esanda kutholakala
Juni 2022: I-Ivosidenib (i-Tibsovo, i-Servier Pharmaceuticals LLC) ihlanganiswe ne-azacitidine igunyazwe yi-Food and Drug Administration ye-acute myeloid leukemia (AML) esanda kutholakala kubantu abadala abaneminyaka engu-75 noma ngaphezulu abane-.
AZA-JMML-001, Inkampani Celgene Corporation, i-leukemia yengane ye-myelomonocytic, I-NCT02447666, IVidaza
I-Azacitidine igunyazwe yi-FDA nge-leukemia yentsha ye-myelomonocytic esanda kutholwa
Juni 2022: I-FDA igunyaze umuthi i-azacitidine (Vidaza, Celgene Corp.) wezingane ezine-juvenile myelomonocytic leukemia (JMML) esanda kutholwa. I-pharmacokinetics, i-pharmacodynamics, ukuphepha, nomsebenzi we-azacitidine p.
I-leukemia ebuntwaneni, I-leukemia engapheli, i-induction chemotherapy, I-leukemia, i-leukemia yezingane
I-leukemia yezingane kanye nokwelashwa kwayo
Leukemia in childhood Leukemia is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood leukemias are acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Chronic leu..
I-Burkitt lymphoma, I-Burkitt-like lymphoma, I-DLBCL, I-Genentech, I-Rituxan, I-Rituximab
I-Rituximab plus chemotherapy igunyazwe yi-FDA ngezinkomba zomdlavuza wezingane
Mashi 2022: I-Food and Drug Administration igunyaze i-rituximab (Rituxan, Genentech, Inc.) ngokuhlanganyela ne-chemotherapy ye-CD20-positive diffuse big-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
I-Asciminib, I-leukemia ye-myeloid engapheli, I-Novartis AG, Ph+ CML, I-chromosome ye-Philadelphia, Scemblix
I-Asciminib igunyazelwe i-Philadelphia chromosome-positive chronic myeloid leukemia
Nov 2021: I-Asciminib (Scemblix, Novartis AG) yanikezwa ukugunyazwa okusheshisiwe yi-Food and Drug Administration ezigulini ezine-Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) esigabeni esingamahlalakhona (CP) ebesine-pr.
IBHOLA, I-Brexucabtagene autoleucel, IKite Pharma, UTecartus, ZUMA-3
I-Brexucabtagene autoleucel igunyazwe yi-FDA ngokubuyela emuva noma i-refractory B-cell precursor acute lymphoblastic leukemia
October 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). In..